Skip to main content
SpringerLink
Log in

Extent of Surgery for Low-Risk Papillary Thyroid Cancer

  • Chapter
  • First Online:
Controversies in Thyroid Nodules and Differentiated Thyroid Cancer

  • 150 Accesses

Abstract

Low-risk differentiated thyroid cancers (DTC) are defined as tumors that are less than 4 cm in size without evidence of extrathyroidal extension or nodal disease (in patients without a family history of thyroid cancer or personal history of radiation to the head and neck). Treatment options for low-risk DTC can include total thyroidectomy, ipsilateral thyroid lobectomy, or active surveillance. In this chapter, we discuss criteria for determining the optimal treatment strategies for patients with low-risk DTC, using clinical and radiographic features.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017;24:332–6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. SEER Cancer Stat Facts. Thyroid cancer. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/statfacts/html/thyro.html

  3. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.

    Article  CAS  PubMed  Google Scholar 

  4. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent Tumors. JAMA Oncol. 2016;2(8):1023–9. https://doi.org/10.1001/jamaoncol.2016.0386.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yu XM, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254:653–60.

    Article  PubMed  Google Scholar 

  7. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–7.

    Article  PubMed  Google Scholar 

  8. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.

    Article  PubMed  Google Scholar 

  9. Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143:1015–20.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Macedo FI, Mittal VK. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: a meta-analysis. Surg Oncol. 2015;24:117–22.

    Article  PubMed  Google Scholar 

  11. Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr Pract. 2007;13:498–512.

    Article  PubMed  Google Scholar 

  12. Guan H, Vandenbussche CJ, Erozan YS, et al. Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy. Acta Cytol. 2013;57:534–42.

    Article  PubMed  Google Scholar 

  13. Das DK, Mallik MK, Sharma P, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant. Acta Cytol. 2004;48:325–36.

    Article  PubMed  Google Scholar 

  14. Xing M, Clark D, Guan H, et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol. 2009;27:2977–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Xing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32:2718–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yip L, Gooding WE, Nikitski A, Wald AI, Carty SE, Karslioglu-French E, Seethala RR, Zandberg DP, Ferris RL, Nikiforova MN, Nikiforov YE. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: a matched case-control study. Cancer. 2021;127(11):1779–87. https://doi.org/10.1002/cncr.33421. Epub 2021 Feb 4. PMID: 33539547; PMCID: PMC8113082

    Article  PubMed  Google Scholar 

  17. Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260:601–5.; discussion 605-7.

    Article  PubMed  Google Scholar 

  18. Vargas-Pinto S, Romero Arenas MA. Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review. J Surg Res. 2019;242:244–51. https://doi.org/10.1016/j.jss.2019.04.036. Epub 2019 May 16. PMID: 31103828

    Article  PubMed  Google Scholar 

  19. Vaisman F, Shaha A, Fish A, Tuttle AS. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol. 2011;75:112–9.

    Article  CAS  Google Scholar 

  20. Matsuzu K, Sugino K, Masudo K, et al. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014;38:68–79.

    Article  PubMed  Google Scholar 

  21. Kim SY, Kim HJ, Kim SM, et al. Thyroid hormone supplementation therapy for differentiated thyroid cancer after lobectomy: 5 years of follow-up. Front Endocrinol (Lausanne). 2020;11:520.

    Article  PubMed  Google Scholar 

  22. Park JO, Bae JS, Lee SH, et al. The Long-term prognosis of voice pitch change in female patients after thyroid surgery. World J Surg. 2016;40:2382–90.

    Article  PubMed  Google Scholar 

  23. Kandil E, Krishnan B, Noureldine SI, et al. Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec. 2013;75:6–17.

    Article  CAS  PubMed  Google Scholar 

  24. Hauch A, Al-Qurayshi Z, Randolph G, et al. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol. 2014;21:3844–52.

    Article  PubMed  Google Scholar 

  25. McDow AD, Saucke MC, Marka NA, Long KL, Pitt SC. Thyroid lobectomy for low-risk papillary thyroid cancer: a National Survey of low- and high-volume surgeons. Ann Surg Oncol. 2021;28(7):3568–75. https://doi.org/10.1245/s10434-021-09898-9. Epub 2021 May 3

    Article  PubMed  Google Scholar 

  26. Patel KN, Yip L, Lubitz CC, et al. Executive summary of the American Association of Endocrine Surgeons Guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg. 2020;271:399–410.

    Article  PubMed  Google Scholar 

  27. Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Chung KW, Shong YK, Lee JH. Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid. 2019;29(10):1399–408. https://doi.org/10.1089/thy.2019.0159.

    Article  PubMed  Google Scholar 

  28. Sawka AM, Thabane L. Active surveillance of low-risk papillary thyroid cancer: a meta-analysis-methodologic critiques and tips for addressing them [published online ahead of print, 2020 Apr 9]. Surgery. 2020;168(5):975.

    Article  PubMed  Google Scholar 

  29. Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016;40(3):516–22. https://doi.org/10.1007/s00268-015-3392-y.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Saravana-Bawan B, Bajwa A, Paterson J, et al. Active surveillance of low-risk papillary thyroid cancer: a meta-analysis. Surgery. 2020;167:46–55.

    Article  PubMed  Google Scholar 

  31. Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26:144–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sawka AM, Ghai S, Tomlinson G, et al. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer. BMJ Open. 2018;8(4):e020298. https://doi.org/10.1136/bmjopen-2017-020298.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Davies L, Chang CH, Sirovich B, Tuttle RM, Fukushima M, Ito Y, Miyauchi A. Thyroid cancer active surveillance program retention and adherence in Japan. JAMA Otolaryngol Head Neck Surg. 2021;147(1):77–84. https://doi.org/10.1001/jamaoto.2020.4200.

    Article  PubMed  Google Scholar 

  35. McCaffery KJ, Nickel B. Clinician be my guide in active surveillance of papillary thyroid microcarcinoma. JAMA Otolaryngol Head Neck Surg. 2021;147(1):7–8. https://doi.org/10.1001/jamaoto.2020.4237.

    Article  PubMed  Google Scholar 

  36. Sugitani I, Ito Y, Takeuchi D, Nakayama H, Masaki C, Shindo H, Teshima M, Horiguchi K, Yoshida Y, Kanai T, Hirokawa M, Hames KY, Tabei I, Miyauchi A. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid. 2021;31(2):183–92. https://doi.org/10.1089/thy.2020.0330. Epub 2020 Nov 2. PMID: 33023426; PMCID: PMC7891203.

  37. Ahmadi S, Gonzalez JM, Talbott M, et al. Patient preferences around extent of surgery in low-risk thyroid cancer: a discrete choice experiment. Thyroid. 2020;30:1044–52.

    Article  PubMed  Google Scholar 

  38. Nickel B, Howard K, Brito JP, et al. Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment. JAMA Otolaryngol Head Neck Surg. 2018;144:887–96.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sawka AM, Ghai S, Yoannidis T, Rotstein L, Gullane PJ, et al. A prospective mixed-methods study of decision-making on surgery or active surveillance for low-risk papillary thyroid cancer. Thyroid. 2020;30(7):999–1007. https://doi.org/10.1089/thy.2019.0592.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Endocrine Surgery, Duke University Medical Center, Durham, NC, USA

    Jessica Dahle & Hadiza S. Kazaure

  2. Endocrine and General Surgery, Ochsner Health, New Orleans, LA, USA

    Jessica Dahle

Authors
  1. Jessica Dahle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hadiza S. Kazaure
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hadiza S. Kazaure .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Sanziana A. Roman

  2. Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Wen T. Shen

  3. Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Julie Ann Sosa

Ethics declarations

The authors have no disclosures.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dahle, J., Kazaure, H.S. (2023). Extent of Surgery for Low-Risk Papillary Thyroid Cancer. In: Roman, S.A., Shen, W.T., Sosa, J.A. (eds) Controversies in Thyroid Nodules and Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-031-37135-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-37135-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-37134-9

  • Online ISBN: 978-3-031-37135-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation